![](/img/cover-not-exists.png)
887PNegative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)
Bracarda, S., Galli, L., Maruzzo, M., Lo Re, G., Buti, S., Favaretto, A., Costanzo, F.D., Sacco, C., Merlano, M., Mucciarini, C., Zafarana, E., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, MVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx371.041
Date:
September, 2017
File:
PDF, 80 KB
2017